Management of molecular-targeted therapy for chronic myelogenous leukemia.

Journal of the American Academy of Nurse Practitioners

Volumn 15, Issue 7, 2003, Pages 292-296

  Ault, Patricia ^a   Kaled, Suzan ^a   Rios, Mary Beth ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; IMATINIB; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

CHRONIC MYELOID LEUKEMIA; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; HUMAN; NURSING; PRACTICE GUIDELINE; REVIEW; SURVIVAL;

ANTINEOPLASTIC AGENTS; CONTROLLED CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; PIPERAZINES; PRACTICE GUIDELINES; PYRIMIDINES; SURVIVAL ANALYSIS;

EID: 0141462784     PISSN: 10412972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2003.tb01310.x     Document Type: Review

References (34)